EaseMyTrip co-founder to exit company with Rs 780 crore stake sale

EaseMyTrip co-founder Nishant Pitti is set to sell his remaining 14% stake in the company for Rs 780 crore through a block deal scheduled for December 31, according to reports. The transaction involves 50 crore shares priced at Rs 15.6 per unit.

Several prominent institutional investors are reportedly lined up to participate in the deal, including CRAFT Emerging Market Fund PCC’s Citadel Capital Fund and Elite Capital Fund, along with Multitude Growth Funds Limited, Nexpact Limited, and Eminence Global Fund. 

Also ReadAI & beyond: Telangana CM meets Satya Nadella, seeks Microsoft’s support for tech ecosystem

The sale would mark Pitti’s complete exit from EaseMyTrip, the brand operated by the listed entity Easy Trip Planner. This follows Pitti’s earlier significant divestment in September 2023, when he sold 24.65 crore shares, representing 14% of the total share capital, at prices ranging between Rs 37.11 and Rs 38.28 per unit. That transaction was valued at approximately Rs 920 crore.

 » Read More

Related Articles

Muthoot raises AUM growth target to 40% on gold loan surge

Following a surge in demand for gold loans, Muthoot Finance has raised its assets under management (AUM) growth guidance for the fiscal to 40%, from 25-30% earlier. Last week, the country’s largest gold loan lender said its gold loan AUM had crossed Rs 1 lakh crore. As of the December quarter, gold loan AUM stood

Delhi-NCR’s luxury real estate booms with 72% sales surge in 2024

The luxury real estate market in Delhi-NCR is witnessing an extraordinary upswing, with a remarkable 72 percent increase in sales recorded from January to September 2024. Over 34 percent of the homes available for sale in Delhi-NCR are listed at prices of Rs 10 crore or higher, according to data analyzed by eXP India, the

THIS Indian fintech firm outranks Titan and Aditya Birla to become Asia-Pacific’s fastest-growing company

Indian peer-to-peer lending platform Lendbox has secured the top spot in the Financial Times and Statista’s ranking of 500 high-growth Asia-Pacific companies. The ranking recognises companies that have demonstrated exceptional revenue growth between 2020 and 2023. Alongside Lendbox, 80 other Indian firms made it to the list, highlighting India’s expanding economic footprint in the region.

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Stay Connected

0FansLike
0FollowersFollow
0SubscribersSubscribe
- Advertisement -

Latest Articles

Muthoot raises AUM growth target to 40% on gold loan surge

Following a surge in demand for gold loans, Muthoot Finance has raised its assets under management (AUM) growth guidance for the fiscal to 40%, from 25-30% earlier. Last week, the country’s largest gold loan lender said its gold loan AUM had crossed Rs 1 lakh crore. As of the December quarter, gold loan AUM stood

Delhi-NCR’s luxury real estate booms with 72% sales surge in 2024

The luxury real estate market in Delhi-NCR is witnessing an extraordinary upswing, with a remarkable 72 percent increase in sales recorded from January to September 2024. Over 34 percent of the homes available for sale in Delhi-NCR are listed at prices of Rs 10 crore or higher, according to data analyzed by eXP India, the

THIS Indian fintech firm outranks Titan and Aditya Birla to become Asia-Pacific’s fastest-growing company

Indian peer-to-peer lending platform Lendbox has secured the top spot in the Financial Times and Statista’s ranking of 500 high-growth Asia-Pacific companies. The ranking recognises companies that have demonstrated exceptional revenue growth between 2020 and 2023. Alongside Lendbox, 80 other Indian firms made it to the list, highlighting India’s expanding economic footprint in the region.

First in America: Utah passes bill allowing state vendors to be paid in gold and silver

Gold and silver will again become a medium of financial transactions in America. Utah, a state in the USA will be the first state to allow state vendors to be paid in gold and silver. The bill that allows the state of Utah to pay its vendors in gold and silver has been passed in

Zydus Lifesciences soars 3% on US FDA nod for manufacturing Apalutamide Tablets

Zydus Lifesciences rose 3% to an intra-day high of Rs 930 after the company received approval from the US FDA to manufacture Apalutamide Tablets, 60 mg. However, the stock came off highs to trade 0.9% up at Rs 910.40, around 2 PM.  “Zydus Lifesciences Limited (including its subsidiaries/ affiliates, hereafter referred to as “Zydus”) has